Successful implementation and results of an HPV vaccination program in Geneva Canton, Switzerland.
We describe a human papillomavirus (HPV) vaccination program implemented since 2007 in Geneva Canton, Switzerland, that used school services, a public hospital, and private physicians as vaccination providers. We assessed program performance with the evolution of immunization coverage during the first four years of program implementation. We measured vaccination coverage of the target population using individual records of vaccination status collected by service providers and transmitted to the Geneva Canton Medical Office. The target population was 20,541 adolescent girls aged 11-19 years as of September 1, 2008, who resided in the canton when the program began. As of June 30, 2012, HPV vaccination coverage was 72.6% and 74.8% in targeted cohorts for three and two doses, respectively. The global coverage for three doses increased by 27 percentage points from December 2009 to June 2012. Coverage for girls aged 16-18 years at the beginning of the program reached 80% or more four years into the program. High coverage by this HPV vaccination program in Geneva was likely related to free vaccination and easy access to the vaccine using a combination of delivery services, including school health services, a public hospital, and private physicians, covering most eligible adolescent girls.
University of Applied Sciences Western Switzerland, Haute Ecole de Santé, Geneva, Switzerland ; University of Geneva, Institute of Global Health, Faculty of Medicine, Geneva, Switzerland ; School Health Service, Department of Public Instruction, Geneva, Switzerland.
Emilien
E
Jeannot
University Hospitals of Geneva, Department of Gynecology and Obstetrics, Geneva, Switzerland.
Patrick
P
Petignat
Cantonal Medical Service, Department of Regional Affairs, Prevention and Health Promotion Section, Geneva, Switzerland.
Philippe
P
Sudre
D000293:Adolescent; D005260:Female; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration*; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D011320:Primary Health Care / Q000458:organization & administration*; D012572:School Health Services / Q000458:organization & administration*; D013557:Switzerland
D053918:Papillomavirus Vaccines